private healthcare

Covid-19 represented a perfect storm for both public and private healthcare providers. This year looks to be equally challenging.

SINGAPORE (Aug 15): Q&M Dental Group announced group earnings increased more than trebled to $13.64 million for 2Q17 from $3.7 million in 2Q16 due to a one-time $16.9 million gain from Q&M’s spin-off of Aoxin from an subsidiary to an associate in April.

SINGAPORE (June 9): IHH Healthcare, together with its strategic partner Taikang Insurance Group and joint venture (JV) partner Shanghai Hongxin Medical Investment Holding, today broke ground for Gleneagles Shanghai Hospital.

SINGAPORE (June 5): Maybank Kim Eng Research continues to rate Raffles Medical Group (RMG) at “buy” as Singapore’s leading integrated healthcare provider, with a “robust track record and exciting development plans” of two hospitals in China.

SINGAPORE (March 15): Health Management International (HMI) announced that its recent renounceable non-underwritten 11-for-200 rights issue was 145.7% subscribed, raising gross proceeds of roughly $18.5 million.

SINGAPORE (Jan 12): Maybank Kim Eng is maintaining its “buy” call on Raffles Medical Group with an unchanged target price of $1.85 as the research house remains positive on the stock’s long-term growth, particularly in the case of its overseas proje